| Post |
| Pre |
| LA |
|---|
| - |
| - |
| ME 1 | ME 2 | ME 3 | ME 4 | ME 5 | ME 6 | ME 7 | ME 8 | ME 9 | ME 10 | Total |
|---|---|---|---|---|---|---|---|---|---|---|
| - | - | - | - | - | - | - | - | - | - | - |
| - | - | - | - | - | - | - | - | - | - | - |
| Post |
| Pre |
| LO 1 | LO 2 | LO 3 | LO 4 | LO 5A | LO 5B | LO 6 | Total |
|---|---|---|---|---|---|---|---|
| - | - | - | - | - | 1 | 186 | 187 |
| - | - | - | - | - | - | 3 | 3 |
| AME |
|---|
| - |
| - |
| Post |
| Pre |
| LOP 1 | LOP 2 | LOP 3 | LOP 4 | Total |
|---|---|---|---|---|
| - | - | - | - | - |
| - | - | - | - | - |
| central brain |
|---|
| 206 |
| 315 |

| ROI Name | ∑ In | % In | log ratio | ∑ Out | % Out |
|---|---|---|---|---|---|
| LH(L) | 40 | 10.0% | 2.67 | 254 | 79.1% |
| LO(L) | 187 | 46.8% | -5.96 | 3 | 0.9% |
| PLP(L) | 135 | 33.8% | -6.08 | 2 | 0.6% |
| SLP(L) | 7 | 1.8% | 2.28 | 34 | 10.6% |
| AVLP(L) | 8 | 2.0% | 1.00 | 16 | 5.0% |
| CentralBrain-unspecified | 12 | 3.0% | -3.58 | 1 | 0.3% |
| Optic-unspecified(L) | 7 | 1.8% | -1.22 | 3 | 0.9% |
| PVLP(L) | 1 | 0.2% | 2.58 | 6 | 1.9% |
| SCL(L) | 3 | 0.8% | -0.58 | 2 | 0.6% |
| upstream partner | # | NT | conns LoVP105 | % In | CV |
|---|---|---|---|---|---|
| Tm31 (L) | 9 | GABA | 33 | 9.2% | 0.7 |
| Tm16 (L) | 11 | ACh | 22 | 6.1% | 0.6 |
| TmY20 (L) | 5 | ACh | 20 | 5.6% | 0.7 |
| Tm37 (L) | 11 | Glu | 20 | 5.6% | 0.8 |
| LoVP100 (L) | 1 | ACh | 15 | 4.2% | 0.0 |
| Tm34 (L) | 5 | Glu | 12 | 3.3% | 0.8 |
| LHPV4a11 (L) | 1 | Glu | 9 | 2.5% | 0.0 |
| LoVP34 (L) | 1 | ACh | 9 | 2.5% | 0.0 |
| TmY17 (L) | 4 | ACh | 9 | 2.5% | 0.4 |
| MeVP11 (L) | 4 | ACh | 9 | 2.5% | 0.4 |
| LC43 (L) | 1 | ACh | 8 | 2.2% | 0.0 |
| MeVP25 (L) | 1 | ACh | 8 | 2.2% | 0.0 |
| PLP095 (L) | 2 | ACh | 7 | 1.9% | 0.1 |
| LC40 (L) | 4 | ACh | 6 | 1.7% | 0.6 |
| TmY10 (L) | 5 | ACh | 6 | 1.7% | 0.3 |
| LC41 (L) | 2 | ACh | 5 | 1.4% | 0.6 |
| LoVP14 (L) | 3 | ACh | 5 | 1.4% | 0.3 |
| Li20 (L) | 4 | Glu | 5 | 1.4% | 0.3 |
| PLP185 (L) | 1 | Glu | 4 | 1.1% | 0.0 |
| LHCENT9 (L) | 1 | GABA | 4 | 1.1% | 0.0 |
| Tm36 (L) | 3 | ACh | 4 | 1.1% | 0.4 |
| LC14a-2 (R) | 2 | ACh | 4 | 1.1% | 0.0 |
| Li14 (L) | 4 | Glu | 4 | 1.1% | 0.0 |
| SLP003 (L) | 1 | GABA | 3 | 0.8% | 0.0 |
| LC44 (L) | 1 | ACh | 3 | 0.8% | 0.0 |
| PLP184 (L) | 1 | Glu | 3 | 0.8% | 0.0 |
| M_adPNm3 (L) | 1 | ACh | 3 | 0.8% | 0.0 |
| LHPV7b1 (L) | 1 | ACh | 3 | 0.8% | 0.0 |
| MeVP32 (L) | 1 | ACh | 3 | 0.8% | 0.0 |
| LHCENT6 (L) | 1 | GABA | 3 | 0.8% | 0.0 |
| OA-VUMa6 (M) | 1 | OA | 3 | 0.8% | 0.0 |
| LoVP1 (L) | 2 | Glu | 3 | 0.8% | 0.3 |
| MeVP3 (L) | 3 | ACh | 3 | 0.8% | 0.0 |
| MeTu4f (L) | 3 | ACh | 3 | 0.8% | 0.0 |
| PLP129 (L) | 1 | GABA | 2 | 0.6% | 0.0 |
| ANXXX127 (L) | 1 | ACh | 2 | 0.6% | 0.0 |
| PVLP104 (L) | 1 | GABA | 2 | 0.6% | 0.0 |
| WEDPN2B_a (L) | 1 | GABA | 2 | 0.6% | 0.0 |
| LoVP10 (L) | 1 | ACh | 2 | 0.6% | 0.0 |
| CL099 (L) | 1 | ACh | 2 | 0.6% | 0.0 |
| MeLo4 (L) | 1 | ACh | 2 | 0.6% | 0.0 |
| LC46b (L) | 1 | ACh | 2 | 0.6% | 0.0 |
| LHAV4d5 (L) | 1 | GABA | 2 | 0.6% | 0.0 |
| LHAV2c1 (L) | 1 | ACh | 2 | 0.6% | 0.0 |
| PLP199 (L) | 1 | GABA | 2 | 0.6% | 0.0 |
| CB1308 (L) | 1 | ACh | 2 | 0.6% | 0.0 |
| TmY5a (L) | 1 | Glu | 2 | 0.6% | 0.0 |
| CL080 (L) | 1 | ACh | 2 | 0.6% | 0.0 |
| LHPV6g1 (L) | 1 | Glu | 2 | 0.6% | 0.0 |
| SLP457 (L) | 1 | unc | 2 | 0.6% | 0.0 |
| SLP004 (L) | 1 | GABA | 2 | 0.6% | 0.0 |
| LoVCLo2 (L) | 1 | unc | 2 | 0.6% | 0.0 |
| LHPV6l2 (L) | 1 | Glu | 2 | 0.6% | 0.0 |
| MeVP23 (L) | 1 | Glu | 2 | 0.6% | 0.0 |
| Li39 (R) | 1 | GABA | 2 | 0.6% | 0.0 |
| LoVCLo3 (R) | 1 | OA | 2 | 0.6% | 0.0 |
| 5-HTPMPV03 (R) | 1 | 5-HT | 2 | 0.6% | 0.0 |
| CB3676 (L) | 1 | Glu | 1 | 0.3% | 0.0 |
| LC36 (L) | 1 | ACh | 1 | 0.3% | 0.0 |
| SLP151 (L) | 1 | ACh | 1 | 0.3% | 0.0 |
| SLP056 (L) | 1 | GABA | 1 | 0.3% | 0.0 |
| MeLo1 (L) | 1 | ACh | 1 | 0.3% | 0.0 |
| PLP130 (L) | 1 | ACh | 1 | 0.3% | 0.0 |
| SLP080 (L) | 1 | ACh | 1 | 0.3% | 0.0 |
| LHPV4h3 (L) | 1 | Glu | 1 | 0.3% | 0.0 |
| LHAD1b2_b (L) | 1 | ACh | 1 | 0.3% | 0.0 |
| SLP314 (L) | 1 | Glu | 1 | 0.3% | 0.0 |
| LoVP52 (L) | 1 | ACh | 1 | 0.3% | 0.0 |
| LHPV2e1_a (L) | 1 | GABA | 1 | 0.3% | 0.0 |
| LHAV7a6 (L) | 1 | Glu | 1 | 0.3% | 0.0 |
| CL271 (L) | 1 | ACh | 1 | 0.3% | 0.0 |
| SMP414 (L) | 1 | ACh | 1 | 0.3% | 0.0 |
| AVLP469 (L) | 1 | GABA | 1 | 0.3% | 0.0 |
| CB3001 (L) | 1 | ACh | 1 | 0.3% | 0.0 |
| LHPV4a5 (L) | 1 | Glu | 1 | 0.3% | 0.0 |
| CB4208 (L) | 1 | ACh | 1 | 0.3% | 0.0 |
| CB1448 (L) | 1 | ACh | 1 | 0.3% | 0.0 |
| LHCENT12b (L) | 1 | Glu | 1 | 0.3% | 0.0 |
| Li13 (L) | 1 | GABA | 1 | 0.3% | 0.0 |
| MeVP2 (L) | 1 | ACh | 1 | 0.3% | 0.0 |
| CL136 (L) | 1 | ACh | 1 | 0.3% | 0.0 |
| CB1701 (L) | 1 | GABA | 1 | 0.3% | 0.0 |
| SLP227 (L) | 1 | ACh | 1 | 0.3% | 0.0 |
| LHPV3a1 (L) | 1 | ACh | 1 | 0.3% | 0.0 |
| AVLP044_a (L) | 1 | ACh | 1 | 0.3% | 0.0 |
| Li35 (L) | 1 | GABA | 1 | 0.3% | 0.0 |
| CB1241 (L) | 1 | ACh | 1 | 0.3% | 0.0 |
| MeVP10 (L) | 1 | ACh | 1 | 0.3% | 0.0 |
| LHAV1a3 (L) | 1 | ACh | 1 | 0.3% | 0.0 |
| CB0734 (L) | 1 | ACh | 1 | 0.3% | 0.0 |
| CB1405 (L) | 1 | Glu | 1 | 0.3% | 0.0 |
| LC14b (R) | 1 | ACh | 1 | 0.3% | 0.0 |
| CB2292 (L) | 1 | unc | 1 | 0.3% | 0.0 |
| CL026 (L) | 1 | Glu | 1 | 0.3% | 0.0 |
| CB0396 (L) | 1 | Glu | 1 | 0.3% | 0.0 |
| VC5_lvPN (L) | 1 | ACh | 1 | 0.3% | 0.0 |
| CL365 (R) | 1 | unc | 1 | 0.3% | 0.0 |
| MeVP43 (L) | 1 | ACh | 1 | 0.3% | 0.0 |
| aMe20 (L) | 1 | ACh | 1 | 0.3% | 0.0 |
| LHCENT1 (L) | 1 | GABA | 1 | 0.3% | 0.0 |
| LHAV2d1 (L) | 1 | ACh | 1 | 0.3% | 0.0 |
| LT46 (R) | 1 | GABA | 1 | 0.3% | 0.0 |
| VES013 (L) | 1 | ACh | 1 | 0.3% | 0.0 |
| SLP206 (L) | 1 | GABA | 1 | 0.3% | 0.0 |
| MBON20 (L) | 1 | GABA | 1 | 0.3% | 0.0 |
| DNg104 (R) | 1 | unc | 1 | 0.3% | 0.0 |
| LoVCLo3 (L) | 1 | OA | 1 | 0.3% | 0.0 |
| 5-HTPMPV03 (L) | 1 | 5-HT | 1 | 0.3% | 0.0 |
| LoVC9 (R) | 1 | GABA | 1 | 0.3% | 0.0 |
| DNp27 (R) | 1 | ACh | 1 | 0.3% | 0.0 |
| downstream partner | # | NT | conns LoVP105 | % Out | CV |
|---|---|---|---|---|---|
| LHPV7b1 (L) | 1 | ACh | 48 | 8.8% | 0.0 |
| LHPV4h3 (L) | 1 | Glu | 42 | 7.7% | 0.0 |
| LHPV2b3 (L) | 6 | GABA | 39 | 7.1% | 0.6 |
| CB1405 (L) | 1 | Glu | 38 | 6.9% | 0.0 |
| LHCENT2 (L) | 1 | GABA | 35 | 6.4% | 0.0 |
| LHAV5a8 (L) | 3 | ACh | 30 | 5.5% | 0.6 |
| LHPV10b1 (L) | 1 | ACh | 17 | 3.1% | 0.0 |
| LHAV5c1 (L) | 2 | ACh | 17 | 3.1% | 0.5 |
| CB2880 (L) | 1 | GABA | 16 | 2.9% | 0.0 |
| SLP002 (L) | 1 | GABA | 11 | 2.0% | 0.0 |
| LHAD1c2 (L) | 2 | ACh | 11 | 2.0% | 0.8 |
| CB2045 (L) | 1 | ACh | 10 | 1.8% | 0.0 |
| LHAD1a2 (L) | 3 | ACh | 10 | 1.8% | 0.4 |
| LHAV5a4_a (L) | 1 | ACh | 9 | 1.6% | 0.0 |
| CB1389 (L) | 1 | ACh | 8 | 1.5% | 0.0 |
| LHAV6e1 (L) | 1 | ACh | 8 | 1.5% | 0.0 |
| AVLP079 (L) | 1 | GABA | 8 | 1.5% | 0.0 |
| CB1359 (L) | 3 | Glu | 8 | 1.5% | 0.6 |
| LHPV7a1 (L) | 1 | ACh | 7 | 1.3% | 0.0 |
| CL267 (L) | 1 | ACh | 7 | 1.3% | 0.0 |
| LHPV12a1 (L) | 1 | GABA | 6 | 1.1% | 0.0 |
| LHPD5c1 (L) | 1 | Glu | 5 | 0.9% | 0.0 |
| CL246 (L) | 1 | GABA | 4 | 0.7% | 0.0 |
| LHPV4a11 (L) | 1 | Glu | 4 | 0.7% | 0.0 |
| LHPV4i4 (L) | 1 | Glu | 4 | 0.7% | 0.0 |
| CB2003 (L) | 1 | Glu | 4 | 0.7% | 0.0 |
| LHAD1f2 (L) | 1 | Glu | 4 | 0.7% | 0.0 |
| CB4208 (L) | 2 | ACh | 4 | 0.7% | 0.5 |
| CB4117 (L) | 2 | GABA | 4 | 0.7% | 0.5 |
| LHPD2a2 (L) | 3 | ACh | 4 | 0.7% | 0.4 |
| CB2904 (L) | 1 | Glu | 3 | 0.5% | 0.0 |
| CB2983 (L) | 1 | GABA | 3 | 0.5% | 0.0 |
| LH001m (L) | 1 | ACh | 3 | 0.5% | 0.0 |
| LHAV4a7 (L) | 1 | GABA | 3 | 0.5% | 0.0 |
| SLP099 (L) | 1 | Glu | 3 | 0.5% | 0.0 |
| LHPV3a1 (L) | 1 | ACh | 3 | 0.5% | 0.0 |
| LHAV4b4 (L) | 2 | GABA | 3 | 0.5% | 0.3 |
| LPLC4 (L) | 3 | ACh | 3 | 0.5% | 0.0 |
| LHAV2j1 (L) | 1 | ACh | 2 | 0.4% | 0.0 |
| DNp32 (L) | 1 | unc | 2 | 0.4% | 0.0 |
| LHAD1f1 (L) | 1 | Glu | 2 | 0.4% | 0.0 |
| CB2667 (L) | 1 | ACh | 2 | 0.4% | 0.0 |
| CL364 (L) | 1 | Glu | 2 | 0.4% | 0.0 |
| PAM11 (L) | 1 | DA | 2 | 0.4% | 0.0 |
| LHAV4d4 (L) | 1 | GABA | 2 | 0.4% | 0.0 |
| LHAD1b2_b (L) | 1 | ACh | 2 | 0.4% | 0.0 |
| LHAV4d1 (L) | 1 | unc | 2 | 0.4% | 0.0 |
| LHAD1d1 (L) | 1 | ACh | 2 | 0.4% | 0.0 |
| PVLP008_b (L) | 1 | Glu | 2 | 0.4% | 0.0 |
| LHPD5b1 (L) | 1 | ACh | 2 | 0.4% | 0.0 |
| CL365 (R) | 1 | unc | 2 | 0.4% | 0.0 |
| LHPD4c1 (L) | 1 | ACh | 2 | 0.4% | 0.0 |
| AVLP023 (L) | 1 | ACh | 2 | 0.4% | 0.0 |
| LoVP90a (L) | 1 | ACh | 2 | 0.4% | 0.0 |
| CB1308 (L) | 2 | ACh | 2 | 0.4% | 0.0 |
| Li22 (L) | 2 | GABA | 2 | 0.4% | 0.0 |
| LHAD1b5 (L) | 2 | ACh | 2 | 0.4% | 0.0 |
| LHAV2h1 (L) | 2 | ACh | 2 | 0.4% | 0.0 |
| LHPD3a2_a (L) | 1 | Glu | 1 | 0.2% | 0.0 |
| LPT101 (L) | 1 | ACh | 1 | 0.2% | 0.0 |
| LHAD1b2_d (L) | 1 | ACh | 1 | 0.2% | 0.0 |
| LoVP18 (L) | 1 | ACh | 1 | 0.2% | 0.0 |
| CB4209 (L) | 1 | ACh | 1 | 0.2% | 0.0 |
| LHAD2e3 (L) | 1 | ACh | 1 | 0.2% | 0.0 |
| SLP406 (L) | 1 | ACh | 1 | 0.2% | 0.0 |
| CB3319 (L) | 1 | ACh | 1 | 0.2% | 0.0 |
| CB1574 (L) | 1 | ACh | 1 | 0.2% | 0.0 |
| CB4112 (L) | 1 | Glu | 1 | 0.2% | 0.0 |
| LHPV2e1_a (L) | 1 | GABA | 1 | 0.2% | 0.0 |
| CB2208 (L) | 1 | ACh | 1 | 0.2% | 0.0 |
| LHPV5c1 (L) | 1 | ACh | 1 | 0.2% | 0.0 |
| SLP152 (L) | 1 | ACh | 1 | 0.2% | 0.0 |
| LHPV6a1 (L) | 1 | ACh | 1 | 0.2% | 0.0 |
| CB1838 (L) | 1 | GABA | 1 | 0.2% | 0.0 |
| LHAV2c1 (L) | 1 | ACh | 1 | 0.2% | 0.0 |
| CB1483 (L) | 1 | GABA | 1 | 0.2% | 0.0 |
| LH006m (L) | 1 | ACh | 1 | 0.2% | 0.0 |
| LC16 (L) | 1 | ACh | 1 | 0.2% | 0.0 |
| LHCENT12b (L) | 1 | Glu | 1 | 0.2% | 0.0 |
| CB2064 (L) | 1 | Glu | 1 | 0.2% | 0.0 |
| LHAV3e6 (L) | 1 | ACh | 1 | 0.2% | 0.0 |
| LHAV2b7_a (L) | 1 | ACh | 1 | 0.2% | 0.0 |
| CB3109 (L) | 1 | unc | 1 | 0.2% | 0.0 |
| CB1246 (L) | 1 | GABA | 1 | 0.2% | 0.0 |
| LC10c-2 (L) | 1 | ACh | 1 | 0.2% | 0.0 |
| LHAV4g1 (L) | 1 | GABA | 1 | 0.2% | 0.0 |
| CB1238 (L) | 1 | ACh | 1 | 0.2% | 0.0 |
| CB1503 (L) | 1 | Glu | 1 | 0.2% | 0.0 |
| CB1701 (L) | 1 | GABA | 1 | 0.2% | 0.0 |
| LH002m (L) | 1 | ACh | 1 | 0.2% | 0.0 |
| LoVP14 (L) | 1 | ACh | 1 | 0.2% | 0.0 |
| CB1619 (L) | 1 | GABA | 1 | 0.2% | 0.0 |
| LHAV1d1 (L) | 1 | ACh | 1 | 0.2% | 0.0 |
| LHAV4d5 (L) | 1 | GABA | 1 | 0.2% | 0.0 |
| LHPV4j2 (L) | 1 | Glu | 1 | 0.2% | 0.0 |
| LC10a (L) | 1 | ACh | 1 | 0.2% | 0.0 |
| CB1513 (L) | 1 | ACh | 1 | 0.2% | 0.0 |
| CB3951b (L) | 1 | ACh | 1 | 0.2% | 0.0 |
| CB1237 (L) | 1 | ACh | 1 | 0.2% | 0.0 |
| CB1412 (L) | 1 | GABA | 1 | 0.2% | 0.0 |
| CL023 (L) | 1 | ACh | 1 | 0.2% | 0.0 |
| LH007m (L) | 1 | GABA | 1 | 0.2% | 0.0 |
| Tm37 (L) | 1 | Glu | 1 | 0.2% | 0.0 |
| SLP437 (L) | 1 | GABA | 1 | 0.2% | 0.0 |
| LHAV2k6 (L) | 1 | ACh | 1 | 0.2% | 0.0 |
| LPLC2 (L) | 1 | ACh | 1 | 0.2% | 0.0 |
| VC3_adPN (L) | 1 | ACh | 1 | 0.2% | 0.0 |
| CB1387 (L) | 1 | ACh | 1 | 0.2% | 0.0 |
| VC5_lvPN (L) | 1 | ACh | 1 | 0.2% | 0.0 |
| ATL041 (L) | 1 | ACh | 1 | 0.2% | 0.0 |
| LHAV2b3 (L) | 1 | ACh | 1 | 0.2% | 0.0 |
| LHPV6g1 (L) | 1 | Glu | 1 | 0.2% | 0.0 |
| PLP096 (L) | 1 | ACh | 1 | 0.2% | 0.0 |
| LHAV3k1 (L) | 1 | ACh | 1 | 0.2% | 0.0 |
| LHCENT8 (L) | 1 | GABA | 1 | 0.2% | 0.0 |
| LHCENT9 (L) | 1 | GABA | 1 | 0.2% | 0.0 |
| LHCENT10 (L) | 1 | GABA | 1 | 0.2% | 0.0 |
| DNc02 (R) | 1 | unc | 1 | 0.2% | 0.0 |
| LHAD1g1 (L) | 1 | GABA | 1 | 0.2% | 0.0 |